Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Pricing Experiment Won't Extend To Part D, Senate Panel Told

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS Deputy Administrator Conway's appearance at the Finance Committee prompted questions about a theoretical next demonstration project while members challenged the project currently on the table; Conway suggested some ‘adjustments’ are coming to the proposed Part B demo.


Related Content

Trump, Congress And The Search For Common Ground On Drug Pricing
Part B Reference Pricing Faces 'Clinical' As Well As 'Political' Obstacles
Have You Heard The Latest Rumor On Drug Pricing? Orrin Hatch Has





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts